46514 Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 

of minority health. In addition, it is 

desirable that nominees have: 

(1) Expertise in developing or 

contributing to the development of 

science-based or evidence-based health 

policies and/or programs. This expertise 

may include experience in the analysis, 

evaluation, and interpretation of 

federal/state health or regulatory policy; 

(2) Involvement in national, state, 

regional, tribal, and/or local efforts to 

improve the health status or outcomes 

among racial and ethnic minority 

populations; 

(3) Educational achievement, 

professional certification(s) in healthrelated fields (e.g., health professions, 

allied health, behavioral health, public 

health, health policy, health 

administration/management, etc.), and 

professional experience that will 

support ability to give expert advice on 

issues related to improving minority 

health and eliminating racial and ethnic 

health disparities; 

(4) Expertise in population level 

health data for racial and ethnic 

minority groups. This expertise may 

include survey, administrative, and/or 

clinical data; 

(5) Knowledge and experience in 

health care systems, cultural and 

linguistic competency, social 

determinants of health, evidence-based 

research, data collection (e.g., federal, 

state, tribal, or local data collection), or 

health promotion and disease 

prevention; 

(6) Nationally recognized via peerreviewed publications, professional 

awards, advanced credentials, or 

involvement in national professional 

organizations. 

Requirements for Nomination 

Submission: Nominations should be 

typewritten (one nomination per 

nominator). Nomination package should 

include: (1) A letter of nomination that 

clearly states the name and affiliation of 

the nominee, the basis for the 

nomination (i.e., specific attributes 

which qualify the nominee for service in 

this capacity), and a statement from the 

nominee indicating a willingness to 

serve as a member of the Committee; (2) 

the nominee’s contact information, 

including name, mailing address, 

telephone number, and email address; 

(3) the nominee’s curriculum vitae 

which should not exceed 10 pages; and 

(4) a summary of the nominee’s 

experience and qualification relative to 

the mandatory professional and 

technical criteria listed above. Federal 

employees should not be nominated for 

consideration of appointment to this 

Committee. 

Individuals selected for appointment 

to the Committee shall be invited to 

serve a four-year term. Committee 

members will receive a stipend for 

attending Committee meetings and 

conducting other business in the 

interest of the Committee, including per 

diem and reimbursement for travel 

expenses incurred. 

The Department makes every effort to 

ensure that the membership of a HHS 

federal advisory committee is fairly 

balanced in terms of points of view 

represented and the committee’s 

function. Every effort is made to ensure 

that a broad representation of 

geographic areas, gender, racial and 

ethnic and minority groups, and the 

disabled are given consideration for 

membership on HHS federal advisory 

committees. Appointment to this 

Committee shall be made without 

discrimination because of a person’s 

race, color, religion, sex (including 

pregnancy), national origin, age, 

disability, or genetic information. 

Nominations must state that the 

nominee is willing to serve as a member 

of ACMH and appears to have no 

conflict of interest that would preclude 

membership. An ethics review is 

conducted for each selected nominee; 

therefore, individuals selected for 

nomination will be required to provide 

detailed information concerning such 

matters as financial holdings, 

consultancies, and research grants or 

contracts to permit evaluation of 

possible sources of conflict of interest. 

Individuals selected to serve on the 

ACMH through the nomination process 

will be posted on the OMH Web site 

once selections have been made. 

Authority: 42 U.S.C. 300u–6, Section 

1707 of the Public Health Service Act, 

as amended. The Advisory Committee is 

governed by provisions of Public Law 

92–463, as amended (5 U.S.C. Appendix 

2), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: September 29, 2017. 

Minh Wendt, 

Designated Federal Officer, Advisory 

Committee on Minority Health. 

[FR Doc. 2017–21500 Filed 10–4–17; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Optic Neuropathies, Eye Infection 

and Cornea Injuries: Mechanism of Disease 

and Regeneration. 

Date: October 24, 2017. 

Time: 10:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Alessandra C Rovescalli, 

Ph.D., Scientific Review Officer, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Rm. 5205 

MSC7846, Bethesda, MD 20892, (301) 435– 

1021, rovescaa@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: October 31, 2017. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Donald Scott Wright, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

8363, wrightds@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Gut Immunity and Microbiome. 

Date: October 31, 2017. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Meenakshisundar 

Ananthanarayanan, Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 2178, Bethesda, MD 20892, 301– 

827–6281, ananth.ananthanarayanan@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Toxicology. 

Date: October 31, 2017. 

Time: 1:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 


ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 46515 

Contact Person: Jonathan K Ivins, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2190, 

MSC 7850, Bethesda, MD 20892, (301) 594– 

1245, ivinsj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 29, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–21384 Filed 10–4–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Advanced Laboratories for Accelerating the 

Reach and Impact Research Centers (P50). 

Date: October 27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave. NW., Washington, DC 20037. 

Contact Person: Karen Gavin-Evans, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Boulevard, Room 6153, MSC 

9606, Bethesda, MD 20892, 301–451–2356, 

gavinevanskm@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Fellowships and Dissertation Grants. 

Date: October 31, 2017. 

Time: 12:30 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: David W. Miller, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–9734, 

millerda@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants; National Institutes of Health, HHS) 

Dated: September 29, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–21393 Filed 10–4–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Early 

Stage Testing of Pharmacologic or Devicebased Interventions for the Treatment of 

Mental Disorders. 

Date: October 25, 2017. 

Time: 9:30 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892, 301–443–7861, 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Research Education Programs (R25). 

Date: October 25, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David M. Armstrong, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH Neuroscience Center/ 

Room 6138/MSC 9608, 6001 Executive 

Boulevard, Bethesda, MD 20892–9608, 301– 

443–3534, armstrda@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Silvio O. Conte Centers for Basic 

Neuroscience or Translational Mental Health 

Research (P50). 

Date: November 3, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The St. Regis Washington DC, 923 

16th Street NW., Washington, DC 20006. 

Contact Person: Rebecca Steiner Garcia, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6149, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–4525, 

steinerr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants; National Institutes of Health, HHS) 

Dated: September 29, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–21392 Filed 10–4–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of Support of Competitive 

Research (SCORE) Award Applications. 

Date: November 6, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


ethrower on DSK3G9T082PROD with NOTICES